Literature DB >> 16409763

[Application of lacrimal plug for dry eye patients].

Xue-min Li1, Jun Zhang, Wei Wang.   

Abstract

OBJECTIVE: To observe the availability and efficacy of Smart PLUG in lacrimal plug in the treatment of serious dry eye.
METHODS: Lacrimal plug was applied in 43 patients (72 eyes) in our clinic from July to October in 2004. Questionnaire was used in these patients before the surgery 3 days and repeated after surgery 1 week and 3 months. Slit lamp microscope examination, fluorescent staining for tear break-up time (BUT), Schirmer test I (STI), impression cytology (IC) were carried out at the same time.
RESULTS: Questionnaire indicated most patients complained about dry eye, foreinbody sensation, asthenopia and red eye. These symptoms were relieved obviously after the application of lacrimal plug. Compared with pre-operation, tear production was increased significantly on the surface of eyes and the defect of corneal epithelium was healed in 37 patients (62 eyes). Compared with pre-operation, BUT and STI were increased and elongated on these patients, IC suggests squamous metaplasia of epithelial layer of conjunctiva in these patients was improved.
CONCLUSIONS: Symptoms of patients suffered from dry eye were relieved obviously by using Smart PLUG. Therefore lacrimal plug can be used for patients with serious dry eye by improving tear volume and tear film stability.

Entities:  

Mesh:

Year:  2005        PMID: 16409763

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  2 in total

1.  Effect of lacrimal plugs combined with deproteinized calf blood extract eye gel for filamentary keratitis.

Authors:  Huibin Lv; Ziyuan Liu; Xuemin Li; Wei Wang
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-17

2.  Corneal sensitivity, ocular surface health and tear film stability after punctal plug therapy of aqueous deficient dry eye.

Authors:  Azza Mohamed Ahmed Said; Mona Elsayed Farag; Tarek Mohamed Abdulla; Othman Ali Othman Ziko; Wesam Mohamed Osman
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.